Literature DB >> 8894358

Clinical features associated with a positive anticardiolipin antibody in Irish patients with systemic lupus erythematosus.

I S Gourley1, S A McMillan, A L Bell.   

Abstract

Anticardiolipin antibodies (ACA) are one of a number of autoantibodies found in patients with systemic lupus erythematosus (SLE) and their presence has been associated with clinical features of the antiphospholipid syndrome (APS). The aim of this study was to determine which clinical features are associated with a positive anticardiolipin antibody in Irish patients with SLE. Ninety-five Irish patients with SLE were studied. All were examined thoroughly, had their full history taken, and had case records reviewed. The presence of any clinical feature associated with the APS was noted. Sera from these patients were tested for IgG and IgM ACA. The only significant association found was between a history of venous thrombosis and the presence of ACA, although several other features were more common in ACA positive patients. There were no significant associations with one or other isotype. This study serves as a reminder to consider the possibility of venous thrombosis, and other clinical features, if an SLE patient is positive for ACA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894358     DOI: 10.1007/bf02229642

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

Authors:  D Alarcón-Segovia; M Delezé; C V Oria; J Sánchez-Guerrero; L Gómez-Pacheco; J Cabiedes; L Fernández; S Ponce de León
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

Review 2.  Diagnosis and management of antiphospholipid syndrome.

Authors:  E N Harris
Journal:  Hosp Pract (Off Ed)       Date:  1994-04-15

3.  Phospholipid binding antibodies warrant continued investigation.

Authors:  E N Harris; G Goldsmith; S Pierangeli; A Gharavi; W Branch
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

4.  Hughes syndrome: antiphospholipid antibodies move closer to thrombosis in 1994.

Authors:  M A Khamashta; R A Asherson
Journal:  Br J Rheumatol       Date:  1995-06

Review 5.  Antiphospholipid syndrome within systemic lupus erythematosus.

Authors:  D Alarcon-Segovia
Journal:  Lupus       Date:  1994-08       Impact factor: 2.911

Review 6.  Antiphospholipid antibody syndrome.

Authors:  M D Lockshin
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

Review 7.  Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.

Authors:  R A Roubey
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

8.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

9.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 10.  Clinical manifestations of the antiphospholipid syndrome.

Authors:  D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

View more
  4 in total

Review 1.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

2.  NK T cells provide lipid antigen-specific cognate help for B cells.

Authors:  Elizabeth A Leadbetter; Manfred Brigl; Petr Illarionov; Nadia Cohen; Megan C Luteran; Shiv Pillai; Gurdyal S Besra; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

3.  Synthesis of a novel alpha-galactosyl ceramide haptenated-lipid antigen, a useful tool in demonstrating the involvement of iNKT cells in the production of antilipid antibodies.

Authors:  Natacha Veerapen; Elizabeth A Leadbetter; Michael B Brenner; Liam R Cox; Gurdyal S Besra
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

Review 4.  Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.

Authors:  Paul R J Ames; Mira Merashli; Tommaso Bucci; Daniele Pastori; Pasquale Pignatelli; Alessia Arcaro; Fabrizio Gentile
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.